592 POSTER Obatoclax (GX17–070), a small molecule pan-bcl-2 inhibitor, in combination with docetaxel in a phase I/II trial enrolling patients with relapsed non-small cell lung cancer (NSCLC)
A. Chiappori, C. Williams, D. Northfelt, J. Adams, S. Malik, M. Edelman, P. Rosen, D. Van Echo, M. Berger, E. HauraVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72526-6
File:
PDF, 60 KB
english, 2008